Darin Lippoldt Neurocrine Biosciences Inc (NBIX) insider trading activity

NBIX Quotes by TradingView

Darin Lippoldt is Chief Legal Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 39,740 shares of NBIX, which is worth approximately $5.53 Million. The most recent transaction as insider was on Nov 01, 2022, when has been sold 10,000 shares (Common Stock) at a price of $120.09 per share, resulting in proceeds of $1,200,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.7K
0% 3M change
10.75% 12M change
Total Value Held $5.53 Million

Darin Lippoldt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2022
SELL
Open market or private sale
$1,200,900 $120.09 p/Share
10,000 Reduced 25.49%
29,234 Common Stock
Nov 01 2022
BUY
Exercise of conversion of derivative security
$432,400 $43.24 p/Share
10,000 Added 20.31%
39,234 Common Stock
Oct 27 2022
SELL
Open market or private sale
$566,342 $115.04 p/Share
4,923 Reduced 14.41%
29,234 Common Stock
Oct 27 2022
BUY
Exercise of conversion of derivative security
$212,871 $43.24 p/Share
4,923 Added 12.6%
34,157 Common Stock
Oct 26 2022
SELL
Open market or private sale
$583,957 $115.02 p/Share
5,077 Reduced 14.8%
29,234 Common Stock
Oct 26 2022
BUY
Exercise of conversion of derivative security
$219,529 $43.24 p/Share
5,077 Added 12.89%
34,311 Common Stock
Oct 04 2022
SELL
Open market or private sale
$1,110,400 $111.04 p/Share
10,000 Reduced 25.49%
29,234 Common Stock
Oct 04 2022
BUY
Exercise of conversion of derivative security
$432,400 $43.24 p/Share
10,000 Added 20.31%
39,234 Common Stock
Sep 08 2022
SELL
Bona fide gift
-
100 Reduced 0.34%
29,234 Common Stock
Sep 07 2022
SELL
Bona fide gift
-
100 Reduced 0.34%
29,334 Common Stock
Mar 22 2022
SELL
Open market or private sale
$803,648 $95.05 p/Share
8,455 Reduced 22.34%
29,396 Common Stock
Mar 18 2022
SELL
Open market or private sale
$28,500 $95.0 p/Share
300 Reduced 0.79%
37,851 Common Stock
Feb 08 2022
SELL
Open market or private sale
$72,434 $79.51 p/Share
911 Reduced 2.33%
38,112 Common Stock
Feb 07 2022
SELL
Open market or private sale
$255,626 $80.69 p/Share
3,168 Reduced 7.83%
37,296 Common Stock
Dec 10 2021
SELL
Bona fide gift
-
120 Reduced 0.35%
34,448 Common Stock
Feb 09 2021
SELL
Open market or private sale
$4,221,668 $116.64 p/Share
36,194 Reduced 51.3%
34,361 Common Stock
Feb 09 2021
BUY
Exercise of conversion of derivative security
$1,302,622 $35.99 p/Share
36,194 Added 47.27%
40,369 Common Stock
Feb 08 2021
SELL
Open market or private sale
$397,665 $116.72 p/Share
3,407 Reduced 9.02%
34,361 Common Stock
Feb 05 2021
SELL
Open market or private sale
$69,000 $114.05 p/Share
605 Reduced 1.94%
30,627 Common Stock
Nov 12 2020
SELL
Open market or private sale
$204,755 $90.72 p/Share
2,257 Reduced 6.98%
30,082 Common Stock
DL

Darin Lippoldt

Chief Legal Officer
San Diego, CA

Track Institutional and Insider Activities on NBIX

Follow NEUROCRINE BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBIX